[1]
Poppel, A. and Mauthe, T. 2025. Assessing the Impact of Approval of Mifegymiso on Abortion Access and Care in Canada. Health Reform Observer – Observatoire des Réformes de Santé. 12, 3 (Dec. 2025). DOI:https://doi.org/10.13162/hro-ors.v12i3.6693.